Advanced Asset Management Advisors Inc Edwards Lifesciences Corp Transaction History

Advanced Asset Management Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$106.37 - $130.68 $3.1 Million - $3.8 Million	-29,100 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $1.12 Million - $1.49 Million	19,400 Added 200.0%	29,100 $2.01 Million
Q2 2019 Aug 02, 2019	BUY	$55.74 - $64.41 $167,220 - $193,230	3,000 Added 44.78%	9,700 $1.79 Million
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $226,393 - $263,913	6,700	6,700 $755,000

1,378

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.